CBDYOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Target Group Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap: $431.92K
P/E (TTM): –
Dividend yield: –

Dividends

Target has not reported a dividend

No dividend per share appears in Target's annual filings since fiscal 2013.

Where these numbers come from

Parsed from the XBRL in Target's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-1000 reverse split on Nov 1, 2017
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CBDY.

Revenue growth-30.7% · median 54.5%

Gross margin39.2% · median -13.8%

Net margin-52.1% · median -340.1%

Company	Revenue	Growth
HYEX	$6.29M	+84.1%
CBDY	$3.50M	-30.7%
CPMD	$1.70M	+24.8%
AKAN	–	–
LEEEF	–	–
CWLXF	–	–

Company

Exchange: OTC
Industry: Medicinal Chemicals & Botanical Products
Fiscal year ends: December 31
Employees: 40
Auditor: Fruci & Associates II, PLLC
SEC CIK: 1586554

Advertisement
300 × 250